Evidence map›Paper›PMID 27718247›Full record

ArticleFEBS letters2016

TIM29 is a subunit of the human carrier translocase required for protein transport.

Sylvie Callegari, Frank Richter, Katarzyna Chojnacka, Daniel C Jans, Isotta Lorenzi, David Pacheu-Grau, Stefan Jakobs, Christof Lenz, Henning Urlaub, Jan Dudek and 2 more

Open access · hybridAbstract readLetter
In one paragraph

Article in FEBS letters, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 71 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. From the cytosol to the inner membrane: biogenesis of the mitochondrial carrier family.Protein science : a publication of the Protein Society · 2026
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Sylvie CallegariDepartment of Cellular Biochemistry, University Medical Center Göttingen, Germany.
Frank RichterDepartment of Cellular Biochemistry, University Medical Center Göttingen, Germany.
Katarzyna ChojnackaInternational Institute of Molecular and Cell Biology, Warsaw, Poland.
Daniel C JansDepartment of NanoBiophotonics, Mitochondrial Structure and Dynamics Group, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany.
Isotta LorenziDepartment of Cellular Biochemistry, University Medical Center Göttingen, Germany.
David Pacheu-GrauDepartment of Cellular Biochemistry, University Medical Center Göttingen, Germany.
Stefan JakobsDepartment of NanoBiophotonics, Mitochondrial Structure and Dynamics Group, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany.
Christof LenzBioanalytical Mass Spectrometry Group, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany.
Henning UrlaubBioanalytical Mass Spectrometry Group, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany.
Jan DudekDepartment of Cellular Biochemistry, University Medical Center Göttingen, Germany.
Agnieszka ChacinskaInternational Institute of Molecular and Cell Biology, Warsaw, Poland.
Peter RehlingDepartment of Cellular Biochemistry, University Medical Center Göttingen, Germany.
Universitätsmedizin Göttingen · DEInternational Institute of Molecular and Cell Biology · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hydrophobic inner mitochondrial membrane proteins with internal targeting signals, such as the metabolite carriers, use the carrier translocase (TIM22 complex) for transport into the inner membrane. Defects in this transport pathway have been associated with neurodegenerative disorders. While the TIM22 complex is well studied in baker's yeast, very little is known about the mammalian TIM22 complex. Using immunoprecipitation, we purified the human carrier translocase and identified a mitochondrial inner membrane protein TIM29 as a novel component, specific to metazoa. We show that TIM29 is a constituent of the 440 kDa TIM22 complex and interacts with oxidized TIM22. Our analyses demonstrate that TIM29 is required for the structural integrity of the TIM22 complex and for import of substrate proteins by the carrier translocase.

Indexed as

Amino Acid SequenceHEK293 CellsHeLa CellsHumansMitochondriaMitochondrial Membrane Transport ProteinsMitochondrial Precursor Protein Import Complex ProteinsOxidation-ReductionProtein TransportMitochondrial Membrane Transport ProteinsMitochondrial Precursor Protein Import Complex ProteinsTIMM29 protein, humanTOMM22 protein, humancarrier translocasemembrane proteinmitochondriaprotein translocationTIM22TIM29

Identifiers

PMID27718247
PMCPMC5215392
OpenAlexW2528543496

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.